Drug Manufacturers - Specialty & Generic | Healthcare
Hester Biosciences Limited manufactures and trades in veterinary vaccines and animal health products in India and internationally. It operates through the Poultry Healthcare and Animal Healthcare segments. The company provides poultry vaccines for newcastle disease, infectious bronchitis, infectious bursal, fowl pox, marek's disease, infectious coryza, fowl cholera, inclusion body hepatitis, fowl typhoid, and avian encephalomyelitis. It also offers vaccines for peste des petits ruminants, goat pox, brucella abortus, lumpy skin disease, contagious bovine pleuropneumonia, and contagious caprine pleuropneumonia; and diagnostic services. In addition, the company provides animal healthcare products, such as biosecurity solutions, therapeutic treatment, herbal supplements, homeopathic remedies, and feed supplements. Further, it offers various pet care products, including gut health solutions, NSAIDs, joint care formulations, parasiticides, grooming aids, and anti-infective formulations. Additionally, the company provides sero-profiling kits, diagnostic labs for poultry flocks, and mastitis control programs for cattle, as well as engages in the manufacturing and trading of goods. Hester Biosciences Limited was incorporated in 1987 and is headquartered in Mehsana, India.
Market Cap
15996299264
Current Price
1880.4
52 Week Range
1242.95 - 3379.0
Previous Close
1899.3
Open
1923.0
Sector
Healthcare
Address
Village Meda - Adraj, Taluka Kadi, Mehsana, 384441, India
Phone
+91-27642-85502
Fax
+91-79264-45105
Website
https://www.hester.in
Day Low
1875.9
Day High
1923.0
Dividend Yield
0.37
PE Ratio
58.234745
Earnings Per Share
32.29
Beta
0.158
EBITDA
620390016
Book Value
369.413
EPS
Name | Title | Age | Year Born |
---|---|---|---|
Mr. Rajiv Dinesh Gandhi B.Com | Executive CEO, MD & Executive Director | 62 | 1962 |
Ms. Priya Rajiv Gandhi | Executive Director | 31 | 1993 |
Mr. Divyesh Maru | Chief Financial Officer | - | - |
Mr. Vinod Mali | Company Secretary & Compliance Officer | - | - |
Dr. Sulochana Shrestha | CEO of Hester Biosciences Nepal Private Limited | - | - |
Dr. Upendra K. Jani | Consultant | 68 | 1956 |
Healthcare • Drug Manufacturers - Specialty & Generic
Healthcare • Drug Manufacturers - Specialty & Generic
Healthcare • Drug Manufacturers - Specialty & Generic
Healthcare • Drug Manufacturers - Specialty & Generic
Healthcare • Drug Manufacturers - Specialty & Generic
Healthcare • Drug Manufacturers - Specialty & Generic
Healthcare • Drug Manufacturers - Specialty & Generic
Healthcare • Drug Manufacturers - Specialty & Generic
Healthcare • Drug Manufacturers - Specialty & Generic
Healthcare • Drug Manufacturers - Specialty & Generic
Find high-momentum stocks with strong forward PE ratios and moderate volatility for aggressive investors.
Explore stocks with high dividend yields and low debt-to-equity ratios for stable income.
Discover large-cap stocks with stable beta for lower volatility and reliable returns.
Find undervalued stocks with reasonable forward PE and market cap for value investors.
Discover stocks with strong 5-year revenue growth trading near their 52-week lows, ideal for long-term investment.
Explore high-beta stocks with significant price movement potential for risk-tolerant investors.
Discover mid to large-cap stocks with strong growth potential and attractive valuations.
Find affordable stocks with consistent dividend payouts for income-focused investors.